Ciulla Thomas 4
4 · Clearside Biomedical, Inc. · Filed Sep 23, 2021
Insider Transaction Report
Form 4
Ciulla Thomas
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-09-21$6.40/sh−2,560$16,384→ 255,560 total
Footnotes (2)
- [F1]The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
- [F2]Includes 4,998 shares acquired under the Issuer's employee stock purchase plan on June 30, 2021.